Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Bizjak

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancers|March 14, 2026
Cannabinoids in Combination with Conventional Breast Cancer Therapies: Mechanistic Insights and the Gap to Clinical TranslationAnja Bizjak, Uroš Potočnik, Helena Čelešnik
Genes|August 28, 2025
Toward Precision Medicine: Molecular Biomarkers of Response to Tofacitinib in Inflammatory Bowel DiseaseAnja Bizjak, Boris Gole, Gregor Jezernik, et al.
Genes|June 28, 2023
Cholecalciferol Supplementation Induced Up-Regulation of <i>SARAF</i> Gene and Down-Regulated miR-155-5p Expression in Slovenian Patients with Multiple SclerosisSaša Gselman, Tanja Hojs Fabjan, Anja Bizjak, et al.
Frontiers in Immunology|March 16, 2026
A functional cell model using basophil activation test to study molecular mechanisms and biomarkers of response to omalizumab treatment in patients with asthmaBoris Gole, Larisa Goričan, Gregor Jezernik, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancers|March 14, 2026
Cannabinoids in Combination with Conventional Breast Cancer Therapies: Mechanistic Insights and the Gap to Clinical TranslationAnja Bizjak, Uroš Potočnik, Helena Čelešnik
Genes|August 28, 2025
Toward Precision Medicine: Molecular Biomarkers of Response to Tofacitinib in Inflammatory Bowel DiseaseAnja Bizjak, Boris Gole, Gregor Jezernik, et al.
Genes|June 28, 2023
Cholecalciferol Supplementation Induced Up-Regulation of <i>SARAF</i> Gene and Down-Regulated miR-155-5p Expression in Slovenian Patients with Multiple SclerosisSaša Gselman, Tanja Hojs Fabjan, Anja Bizjak, et al.
Frontiers in Immunology|March 16, 2026
A functional cell model using basophil activation test to study molecular mechanisms and biomarkers of response to omalizumab treatment in patients with asthmaBoris Gole, Larisa Goričan, Gregor Jezernik, et al.
Pageof 1